Clinical Practice Supports image

Care of the COVID-19 Patient

This guide is created for teams who care for COVID-19 patients in acute care settings. The goal of this guide is to support unit-based education, develop COVID-19 core competencies to care for patients with increasing acuity, with a focus on key elements of a patient-centred plan of care.

This guide provides an overview of COVID-19, current treatments, key elements to be considered, and additional resources. There is a section for practitioners who will care for higher acuity patients either within an Intermediate Care Unit (IMCU) or beginner practitioners within Critical Care environments.

The introduction and overview information below and on the COVID-19 Patient Care page applies to all care areas. As care needs escalate, the level of care may change and care interventions may change as appropriate.

Disclaimer: In view of ongoing research, changes in public health/government regulations, and the constant flow of information relating to practice, team members should regularly consult clinical practice reference sources, including the ERIN Hub.

The content in this guide should not replace specific decisions for individual patients, nor substitute shared decision-making between patients/families and physicians/other health care professionals.

Cause

Coronaviruses are a large family of viruses that usually cause mild to moderate upper respiratory illnesses, like a common cold.

SARS coronavirus (SARS-CoV) occurred in 2002 and caused Severe Acute Respiratory Syndrome (SARS). SARS virus disappeared in 2004.

Middle Eastern Respiratory Syndrome (MERS) appeared in 2012. It is caused by the MERS coronavirus (MERS-CoV) (National Institute of Allergy and Infectious Diseases, 2021).

The virus SARS-CoV-2 appeared in late 2019 and causes COVID-19 (WHO, 2021).

Genetic variations of a virus are common and expected. SARS-CoV2 will naturally develop mutations. There are a number of variants the Canadian government is monitoring.

Transmission

COVID-19 spreads from an infected person to others via respiratory droplets or aerosols that are created when an infectious person coughs, sneezes, sings, shouts, or talks.

The infectiousness of droplets varies; droplets may come in direct contact with the mucous membranes (person’s nose, mouth or eyes), or they may be inhaled via nose, mouth, airways and lungs.

SARS-CoV2 virus may also spread when a person touches a surface or object (fomite) that has the virus on it and then touches their mouth, nose or eyes with unwashed hands.

Transmission may occur from individuals who do not have signs or symptoms of infection (pre-symptomatic or asymptomatic).

(Government of Canada, 2021b, 2021d)

Risk Factors

Currently, those at greatest risk of infection are persons who have had prolonged, unprotected close contact (i.e. within 6 feet for 15 minutes or longer) with a patient with confirmed SARS-CoV-2 infection, regardless of whether the patient has symptoms. Persons frequently in congregate settings (e.g. homeless shelters, assisted living facilities, college or university dormitories) are at increased risk of acquiring infection because of the increased likelihood of close contact. Those who live in or have recently been to areas with sustained transmission may also be at higher risk of infection.

All persons can reduce the risk to themselves and others by wearing a mask, practising physical distancing, washing their hands often, and following other Public health recommendations.

Prevention

Vaccinations

Vaccinations, following public health guidance, and following IPAC guidance are the best strategies to prevent the spread of COVID-19 (Government of Canada, 2021b).

Several vaccines have been approved by Health Canada to prevent COVID-19. Read more information regarding Canadian vaccines (Government of Canada, 2021b).

Public Health Guidance

How to protect yourself and others from COVID-19. Steps you can take to stay safe, help prevent the spread of COVID-19 and protect your community:

Monitoring for COVID-19

  • Healthcare workers who test positive for COVID-19 must remain off work for five days following symptom onset or date of test. Upon return to work, they must wear a mask up to and including day 10
  • Healthcare providers who test negative, or if no test result is available, must remain off work until symptoms have improved or resolved and are without a fever for 24 hours. Upon return to work, they must mask up to 10 days from the onset of symptoms. 
  • Rapid tests remain available for ordering by leaders via SAP. See memos for details: 

 

Canadian Institute for Healthcare Improvement. (2021). COVID-19 cases and deaths in health care workers in Canada — infographic. https://www.cihi.ca/en/covid-19-cases-and-deaths-in-health-care-workers-in-canada-infographic

Government of Canada. (2021a). Coronavirus disease (COVID-19): Outbreak update. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection.html

Government of Canada. (2021b). Coronavirus disease (COVID-19): Prevention and risks.https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks.html

Government of Canada. (2021c). Hospitalizations, intensive care unit (ICU), mechanical ventilation and deaths. Retrieved March 3, 2021 from https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html#a7

Government of Canada. (2021d). Infection prevention and control for COVID-19: Interim guidance for acute healthcare settings. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/infection-prevention-control-covid-19-second-interim-guidance.html

Government of Nova Scotia. (2021a). Coronavirus (COVID-19): Avoiding infection. https://novascotia.ca/coronavirus/avoiding-infection/

Government of Nova Scotia. (2021b). Coronavirus (COVID-19): Case data. https://novascotia.ca/coronavirus/data/#overview

Lycan-Lang, E. (2020). Nova Scotia’s first COVID-19 vaccinations begin today. Halifax Examiner. https://www.halifaxexaminer.ca/featured/nova-scotias-first-covid-19-vaccinations-begin-today/

National Institute of Allergy and Infectious Disease. (2020). Coronaviruses. https://www.niaid.nih.gov/diseases-conditions/coronaviruses

Nova Scotia Health. (2020a). COVID-19 symptom monitoring for inpatients in acute care. COVID-19 Hub. http://policy.nshealth.ca/Site_Published/covid19/document_render.aspx?documentRender.IdType=6&documentRender.GenericField=&documentRender.Id=77460

Nova Scotia Health. (2020b). COVID-19 symptom monitoring for residents in LTC. COVID-19 Hub. http://policy.nshealth.ca/Site_Published/covid19/document_render.aspx?documentRender.IdType=6&documentRender.GenericField=&documentRender.Id=80537

Nova Scotia Health. (2020c). Novel coronavirus COVID-2019 - Overview and personal protective equipment requirements. COVID-19 Hub. http://policy.nshealth.ca/Site_Published/covid19/document_render.aspx?documentRender.IdType=6&documentRender.GenericField=&documentRender.Id=76267

Nova Scotia Health. (2020d). Point of care risk assessment. COVID-19 Hub. http://policy.nshealth.ca/Site_Published/covid19/document_render.aspx?documentRender.IdType=6&documentRender.GenericField=&documentRender.Id=76565

Nova Scotia Health. (2020e). Universal pandemic precautions. COVID-19 Hub. http://policy.nshealth.ca/Site_Published/covid19/document_render.aspx?documentRender.IdType=6&documentRender.GenericField=&documentRender.Id=83021

World Health Organization. (2021). Timeline: WHO’s COVID-19 response. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#event-5